{
  "catalogId": "fde81813-b1bd-4f47-97a9-4346b3554132",
  "name": "TUKYSA 150 MG",
  "status": "draft",
  "category": "prescription",
  "registrationValidity": "valid",
  "registrationNumber": "170 33 36951 99",
  "treatmentDescriptions": "TUKYSA is indicated in combination with trastuzumab and capecitabine for the treatment of adult patients with HER2-positive locally advanced or metastatic breast cancer who have received at least 2 prior anti-HER2 treatment regimens.",
  "termsOfIssue": "Prescription required",
  "form": "film coated tablets",
  "route": "per os",
  "site": "",
  "method": "",
  "administrationNotes": "",
  "ingredients": "TUCATINIB",
  "codes": {
    "atc5": {
      "system": "WHO ATC Classification",
      "code": "L01EH03",
      "name": "TUCATINIB"
    }
  },
  "contraindications": "",
  "sideEffect": "",
  "warnings": "תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת",
  "alternativeMedications": [],
  "packaging": [
    {
      "name": "TUKYSA 150 MG 84 TABS",
      "manufacturer": {
        "name": "פיזר",
        "countryOfOrigin": "IL"
      },
      "strength": {
        "value": 0,
        "unit": ""
      },
      "quantity": {
        "value": 84.0,
        "unit": "units"
      },
      "packagingDescription": "BLISTER PVC/OPA/AL",
      "shelfLife": "24",
      "storageConditions": "",
      "codes": {
        "moh": "9039",
        "yarpa": "63176",
        "barcode": "5415062123010"
      },
      "manufacturersAdministrationRecommendation": "",
      "pricing": {
        "currency": "ILS",
        "maxWholesalePrice": 16970.96088,
        "retailMargin": 10.0,
        "maxRetailPrice": 18668.05697,
        "maxPriceWithVAT": 22028.30624
      }
    }
  ],
  "metadata": {
    "version": "1.4",
    "lastUpdated": "2025-08-01T12:18:44.440895"
  }
}